Physician

Sara Rebecca Torgerson, D.O.

According to 2025 Medicare claims, Sara Torgerson, D.O. (NPI: 1134391899) practices hematology/oncology in the Minneapolis-St. Paul-Bloomington, MN-WI market, with the plurality of this provider's patient population coming from St. Croix, WI. This provider's primary affiliated billing organization is MINNESOTA ONCOLOGY HEMATOLOGY, PA (NPI: 1528035995; TIN: 411793418) and primary practice location at 54016-4439. Torgerson is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604) and Mayo Clinic Community ACO, LLC (ACO ID: A4617), participating under the MSSP model.

Torgerson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 270 traditional Medicare patients, billed 41,443 HCPCS/CPT codes, and received $640,287 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,400 prescription claims across 241 beneficiaries totaling $3,645,628 in drug costs, led by Ibrance (Palbociclib). DME data shows 57 claims. Open Payments data shows 53 records totaling $96,998. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $441,820 to $640,287. Similarly, Part D prescription costs have moved sharply higher in recent years, from $238,575 to $3,645,628. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.